Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionCrossmark Global Holdings, Inc.
Latest Disclosed Ownership524,989 shares
Latest Disclosed Value $ 73,167,814
Crossmark Global Holdings, Inc. reports 4.88% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 11, 2026 - Crossmark Global Holdings, Inc. filed a 13F-HR form disclosing ownership of 524,989 shares of Gilead Sciences, Inc. (CH:GILD) valued at $73,167,814 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 551,922 shares of Gilead Sciences, Inc.. This represents a change in shares of -4.88% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F GILEAD SCIENCES COM 375558103 524,989 -26,933 -4.88 73,168 8.01 1.0808
2026-02-03 2025-12-31 13F GILEAD SCIENCES COM 375558103 551,922 23,719 4.49 67,743 15.54 0.9663
2025-11-12 2025-09-30 13F GILEAD SCIENCES COM 375558103 528,203 15,182 2.96 58,630 3.08 0.8782
2025-08-08 2025-06-30 13F GILEAD SCIENCES COM 375558103 513,021 -39,563 -7.16 56,879 -8.14 0.9184
2025-04-30 2025-03-31 13F GILEAD SCIENCES COM 375558103 552,584 12,364 2.29 61,917 126,261.22 1.0921
2025-01-16 2024-12-31 13F GILEAD SCIENCES COM 375558103 540,220 8,741 1.64 50 11.36 0.9097
2024-11-04 2024-09-30 13F GILEAD SCIENCES COM 375558103 531,479 34,381 6.92 45 29.41 0.7947
2024-07-29 2024-06-30 13F GILEAD SCIENCES COM 375558103 497,098 11,657 2.40 34 -2.86 0.6519
2024-05-13 2024-03-31 13F GILEAD SCIENCES COM 375558103 485,441 -26,656 -5.21 36 -14.63 0.6817
2024-02-13 2023-12-31 13F GILEAD SCIENCES COM 375558103 512,097 -3,441 -0.67 41 5.13 0.8608
2023-11-08 2023-09-30 13F GILEAD SCIENCES COM 375558103 515,538 3,176 0.62 39 0.00 0.8879
2023-07-31 2023-06-30 13F GILEAD SCIENCES COM 375558103 512,362 43,381 9.25 39 2.63 0.8473
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 468,981 120,885 34.73 39 31.03 0.9157
2023-01-19 2022-12-31 13F GILEAD SCIENCES COM 375558103 348,096 15,462 4.65 30 -99.86 0.7448
2022-11-01 2022-09-30 13F GILEAD SCIENCES COM 375558103 332,634 3,844 1.17 20,520 0.97 0.5694
2022-07-29 2022-06-30 13F GILEAD SCIENCES COM 375558103 328,790 6,787 2.11 20,322 6.16 0.5266
2022-05-11 2022-03-31 13F GILEAD SCIENCES COM 375558103 322,003 91,879 39.93 19,143 14.57 0.4269
2022-01-10 2021-12-31 13F GILEAD SCIENCES COM 375558103 230,124 34,412 17.58 16,709 22.23 0.3629
2021-10-21 2021-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 195,712 46 0.02 13,670 1.45 0.3203
2021-10-13 2021-09-30 13F GILEAD SCIENCES COM 375558103 44,058 -151,608 1,461 0.1672
2021-07-21 2021-06-30 13F GILEAD SCIENCES COM 375558103 195,666 9,677 5.20 13,474 12.10 0.3168
2021-04-15 2021-03-31 13F GILEAD SCIENCES COM 375558103 185,989 177 0.10 12,020 11.04 0.2977
2021-01-14 2020-12-31 13F GILEAD SCIENCES COM 375558103 185,812 -4,856 -2.55 10,825 -10.15 0.2737
2020-10-08 2020-09-30 13F GILEAD SCIENCES COM 375558103 190,668 -7,695 -3.88 12,048 -21.06 0.3379
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM 375558103 198,363 -12,939 -6.12 15,262 -3.39 0.4451
2020-04-28 2020-03-31 13F GILEAD SCIENCES COM 375558103 211,302 -4,011 -1.86 15,797 12.91 0.5653
2020-02-06 2019-12-31 13F GILEAD SCIENCES COM 375558103 215,313 4,564 2.17 13,991 4.75 0.3842
2019-10-09 2019-09-30 13F GILEAD SCIENCES COM 375558103 210,749 -5,624 -2.60 13,357 -8.63 0.3899
2019-07-09 2019-06-30 13F GILEAD SCIENCES COM 375558103 216,373 -2,210 -1.01 14,618 2.87 0.4099
2019-05-02 2019-03-31 13F GILEAD SCIENCES COM 375558103 218,583 6,174 2.91 14,210 6.95 0.4034
2019-01-31 2018-12-31 13F GILEAD SCIENCES COM 375558103 212,409 8,833 4.34 13,286 -15.47 0.4118
2018-11-08 2018-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 203,576 519 0.26 15,718 9.27 0.3989
2018-11-06 2018-09-30 13F GILEAD SCIENCES COM 375558103 203,057 0 14,385
2018-07-31 2018-06-30 13F GILEAD SCIENCES COM 375558103 203,057 -550 -0.27 14,385 -6.29 0.3859
2018-04-16 2018-03-31 13F GILEAD SCIENCES COM 375558103 203,607 -22,187 -9.83 15,350 -5.11 0.3968
2018-02-05 2017-12-31 13F GILEAD SCIENCES COM 375558103 225,794 4,038 1.82 16,176 -9.97 0.3887
2017-10-27 2017-09-30 13F GILEAD SCIENCES COM 375558103 221,756 0 0.00 17,967 0.00 0.4631
2017-10-25 2016-09-30 13F GILEAD SCIENCES COM 375558103 221,756 221,756 17,967 0.4631
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.